New frontiers and pitfalls in cytokine and anti-cytokine therapiesODA, Atsushi.Current pharmaceutical design. 2003, Vol 9, Num 14, issn 1381-6128, 58 p.Serial Issue

Update on rituximabEISENBERG, R.Annals of the rheumatic diseases. 2005, Vol 64, pp iv55-iv57, issn 0003-4967, SUP4Conference Paper

Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumabBONGARTZ, T; HÄRLE, P; FRIEDRICH, S et al.Arthritis and rheumatism. 2005, Vol 52, Num 1, pp 280-282, issn 0004-3591, 3 p.Article

Effects of Fluid Resuscitation Methods on the Pro- and Anti-inflammatory Cytokines and Expression of Adhesion Molecules After Burn InjuryFOLDI, Viktor; LANTOS, Janos; BOGAR, Lajos et al.Journal of burn care & research. 2010, Vol 31, Num 3, pp 480-491, issn 1559-047X, 12 p.Article

Rituximab : Applications in dermatologyFATOURECHI, Mitra M; EL-AZHARY, Rokea A; GIBSON, Lawrence E et al.International journal of dermatology. 2006, Vol 45, Num 10, pp 1143-1155, issn 0011-9059, 13 p.Article

Worse patient VAS occurs at weeks 7 and 8 after infliximab infusionsSHENKER, N; HAIGH, R; CLARKE, A et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 3, pp 502-503, issn 0003-4967, 2 p.Article

Interstitial granulomatous drug reaction to anakinraREGULA, Christie G; HENNESSY, Jeannie; CLARKE, Loren E et al.Journal of the American Academy of Dermatology. 2008, Vol 59, Num 2, issn 0190-9622, S25-S27, SUPArticle

Reversibility of Trastuzumab Cardiotoxicity : Is the Concept Alive and Well?EWER, Michael S; TAN-CHIU, Elizabeth; TELLI, Melinda L et al.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5532-5534, issn 0732-183X, 3 p.Article

From the trastuzumab era to new target therapies : beyond revolutionBARNI, S; PETRELLI, F; CABIDDU, M et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, vi1-vi4, SUP6Conference Paper

Successful treatment with rituximab in a patient with an acquired factor V inhibitorLEBRUN, Agnes; LEROY-MATHERON, Catherine; ARLET, Jean-Benoit et al.American journal of hematology. 2008, Vol 83, Num 2, pp 163-164, issn 0361-8609, 2 p.Article

Trastuzumab -associated peripheral vascular toxicityPANSEGRAU, Gary K; GRANT, Dennis R; NORRIS, Brian et al.Journal of clinical oncology. 2007, Vol 25, Num 11, pp 1438-1440, issn 0732-183X, 3 p.Article

Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumabBINDER, Mascha; VOGTIE, Friederike-Nora; MICHELFELDER, Stefan et al.Cancer research (Baltimore). 2007, Vol 67, Num 8, pp 3518-3523, issn 0008-5472, 6 p.Article

Progress in immunotherapy RituximabEL-HABBASH, Manal M; ALWINDI, Abukris M.Saudi medical journal. 2007, Vol 28, Num 11, pp 1635-1644, issn 0379-5284, 10 p.Article

Clinical Images : B cell depletion in the appendix following rituximab treatmentPARAN, Daphna; TREJ'O, Leonor; CASOI, Dan et al.Arthritis and rheumatism. 2006, Vol 54, Num 7, pp 2151-2151, issn 0004-3591, 1 p.Article

Use of rituximab in two unusual antibody-mediated autoimmune disordersADLER, Matthew; SOLIOTIS, Fotini; THAKRAR, Sonali et al.Journal of the Royal Society of Medicine. 2005, Vol 98, Num 6, pp 271-272, issn 0141-0768, 2 p.Article

Cytokines and anti-cytokines as therapeutics : An updateTAYAL, Vandana; BHUPINDER SINGH KALRA.European journal of pharmacology. 2008, Vol 579, Num 1-3, pp 1-12, issn 0014-2999, 12 p.Article

High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatmentBARTELDS, G. M; WOLBINK, G. J; STAPEL, S et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 9, pp 1249-1250, issn 0003-4967, 2 p.Article

A case of reversible posterior leucoencephalopathy syndrome after rituximab infusionMAVRAGANI, C. P; VLACHOYIANNOPOULOS, P. G; KOSMAS, N et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 11, pp 1450-1451, issn 1462-0324, 2 p.Article

Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: Drug reintroduction can be successfulPERRIN, Francois; NEEL, Antoine; GRAVELEAU, Julie et al.La Presse médicale (1983). 2014, Vol 43, Num 3, pp 319-321, issn 0755-4982, 3 p.Article

Effects of inflammatory and anti-inflammatory cytokines on the boneSCHETT, Georg.European journal of clinical investigation. 2011, Vol 41, Num 12, pp 1361-1366, issn 0014-2972, 6 p.Article

Successful Treatment of Resistant Pseudogout With AnakinraMCGONAGLE, Dennis; AI LYN TAN; MADDEN, Julie et al.Arthritis and rheumatism. 2008, Vol 58, Num 2, pp 631-633, issn 0004-3591, 3 p.Article

Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuriaKOPPEL, Ahrin; LIM, Stephen; OSBY, Melanie et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 10, pp 1902-1904, issn 0041-1132, 3 p.Article

Rituximab in refractory autoimmune bullous diseasesSCHMIDT, E; HUNZELMANN, N; ZILLIKENS, D et al.Clinical and experimental dermatology (Print). 2006, Vol 31, Num 4, pp 503-508, issn 0307-6938, 6 p.Article

Remicade® : l'expérience et la nouveautéCRICKX, Béatrice.Annales de dermatologie et de vénéréologie. 2006, Vol 133, Num 5, issn 0151-9638, 17 p., CAH2Serial Issue

Anti-CD3 priming generates heterogeneous antigen-specific memory CD4 T cellsPATKE, Deepa S; AHMADZADEH, Mojgan; BINGAMAN, Adam W et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 117, Num 2, pp 125-132, issn 1521-6616, 8 p.Article